Cargando…
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
Cyclooxygenase-1 (COX-1) is implicated in ovarian cancer. However, patterns of COX expression and function have been unclear and controversial. In this report, patterns of COX-1 and COX-2 gene expression were obtained from RNA-seq data through The Cancer Genome Atlas. Our analysis revealed markedly...
Autores principales: | Wilson, Andrew J., Fadare, Oluwole, Beeghly-Fadiel, Alicia, Son, Deok-Soo, Liu, Qi, Zhao, Shilin, Saskowski, Jeanette, Uddin, Md. Jashim, Daniel, Cristina, Crews, Brenda, Lehmann, Brian D., Pietenpol, Jennifer A., Crispens, Marta A., Marnett, Lawrence J., Khabele, Dineo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673270/ https://www.ncbi.nlm.nih.gov/pubmed/25972361 |
Ejemplares similares
-
CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes
por: Petersen, Shariska, et al.
Publicado: (2020) -
Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors
por: Beeghly-Fadiel, Alicia, et al.
Publicado: (2018) -
Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records
por: Cozzi, Gabriella D., et al.
Publicado: (2016) -
Discovery of Furanone-Based Radiopharmaceuticals for
Diagnostic Targeting of COX-1 in Ovarian Cancer
por: Uddin, Md. Jashim, et al.
Publicado: (2019) -
Blood type, ABO genetic variants, and ovarian cancer survival
por: Cozzi, Gabriella D., et al.
Publicado: (2017)